Logo image of RMBS

RAMBUS INC (RMBS) Stock Fundamental Analysis

NASDAQ:RMBS - Nasdaq - US7509171069 - Common Stock - Currency: USD

67.4499  +3.01 (+4.67%)

Fundamental Rating

6

Taking everything into account, RMBS scores 6 out of 10 in our fundamental rating. RMBS was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. RMBS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. RMBS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year RMBS was profitable.
RMBS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RMBS reported negative net income in multiple years.
RMBS had a positive operating cash flow in 4 of the past 5 years.
RMBS Yearly Net Income VS EBIT VS OCF VS FCFRMBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

RMBS has a better Return On Assets (14.08%) than 83.33% of its industry peers.
Looking at the Return On Equity, with a value of 16.96%, RMBS is in the better half of the industry, outperforming 76.85% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.08%, RMBS belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for RMBS is significantly below the industry average of 11.99%.
The 3 year average ROIC (4.95%) for RMBS is below the current ROIC(11.08%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.08%
ROE 16.96%
ROIC 11.08%
ROA(3y)8.87%
ROA(5y)3.39%
ROE(3y)10.82%
ROE(5y)3.84%
ROIC(3y)4.95%
ROIC(5y)N/A
RMBS Yearly ROA, ROE, ROICRMBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30 40

1.3 Margins

RMBS has a better Profit Margin (34.03%) than 94.44% of its industry peers.
Looking at the Operating Margin, with a value of 31.88%, RMBS belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
Looking at the Gross Margin, with a value of 80.16%, RMBS belongs to the top of the industry, outperforming 97.22% of the companies in the same industry.
RMBS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 31.88%
PM (TTM) 34.03%
GM 80.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y0.21%
RMBS Yearly Profit, Operating, Gross MarginsRMBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RMBS is destroying value.
RMBS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RMBS Yearly Shares OutstandingRMBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
RMBS Yearly Total Debt VS Total AssetsRMBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 20.51 indicates that RMBS is not in any danger for bankruptcy at the moment.
The Altman-Z score of RMBS (20.51) is better than 87.96% of its industry peers.
There is no outstanding debt for RMBS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.51
ROIC/WACC0.79
WACC14.02%
RMBS Yearly LT Debt VS Equity VS FCFRMBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.3 Liquidity

RMBS has a Current Ratio of 8.26. This indicates that RMBS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 8.26, RMBS belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
RMBS has a Quick Ratio of 7.60. This indicates that RMBS is financially healthy and has no problem in meeting its short term obligations.
RMBS has a better Quick ratio (7.60) than 93.52% of its industry peers.
Industry RankSector Rank
Current Ratio 8.26
Quick Ratio 7.6
RMBS Yearly Current Assets VS Current LiabilitesRMBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.49% over the past year.
The Earnings Per Share has been growing by 14.14% on average over the past years. This is quite good.
EPS 1Y (TTM)4.49%
EPS 3Y10.73%
EPS 5Y14.14%
EPS Q2Q%19.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.46%

3.2 Future

RMBS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.68% yearly.
Based on estimates for the next years, RMBS will show a quite strong growth in Revenue. The Revenue will grow by 9.86% on average per year.
EPS Next Y34.33%
EPS Next 2Y25.14%
EPS Next 3Y20.68%
EPS Next 5YN/A
Revenue Next Year21.91%
Revenue Next 2Y17.32%
Revenue Next 3Y16.47%
Revenue Next 5Y9.86%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RMBS Yearly Revenue VS EstimatesRMBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
RMBS Yearly EPS VS EstimatesRMBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

RMBS is valuated quite expensively with a Price/Earnings ratio of 36.26.
Based on the Price/Earnings ratio, RMBS is valued a bit cheaper than 65.74% of the companies in the same industry.
When comparing the Price/Earnings ratio of RMBS to the average of the S&P500 Index (28.47), we can say RMBS is valued slightly more expensively.
The Price/Forward Earnings ratio is 27.00, which means the current valuation is very expensive for RMBS.
67.59% of the companies in the same industry are more expensive than RMBS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 92.74. RMBS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 36.26
Fwd PE 27
RMBS Price Earnings VS Forward Price EarningsRMBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

61.11% of the companies in the same industry are more expensive than RMBS, based on the Enterprise Value to EBITDA ratio.
75.00% of the companies in the same industry are more expensive than RMBS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.67
EV/EBITDA 29.44
RMBS Per share dataRMBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

RMBS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of RMBS may justify a higher PE ratio.
A more expensive valuation may be justified as RMBS's earnings are expected to grow with 20.68% in the coming years.
PEG (NY)1.06
PEG (5Y)2.56
EPS Next 2Y25.14%
EPS Next 3Y20.68%

0

5. Dividend

5.1 Amount

RMBS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RAMBUS INC

NASDAQ:RMBS (2/5/2025, 3:13:45 PM)

67.4499

+3.01 (+4.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-03 2025-02-03/amc
Earnings (Next)N/A N/A
Inst Owners91.87%
Inst Owner Change-1.13%
Ins Owners0.66%
Ins Owner Change-0.37%
Market Cap7.19B
Analysts81.43
Price Target69.65 (3.26%)
Short Float %2.6%
Short Ratio3.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.16%
Min EPS beat(2)-7.54%
Max EPS beat(2)-2.79%
EPS beat(4)1
Avg EPS beat(4)-6.26%
Min EPS beat(4)-17.56%
Max EPS beat(4)2.85%
EPS beat(8)5
Avg EPS beat(8)-0.86%
EPS beat(12)6
Avg EPS beat(12)-6%
EPS beat(16)10
Avg EPS beat(16)-2%
Revenue beat(2)0
Avg Revenue beat(2)-4.95%
Min Revenue beat(2)-6.73%
Max Revenue beat(2)-3.17%
Revenue beat(4)0
Avg Revenue beat(4)-5.71%
Min Revenue beat(4)-12.45%
Max Revenue beat(4)-0.5%
Revenue beat(8)0
Avg Revenue beat(8)-12.05%
Revenue beat(12)0
Avg Revenue beat(12)-15.09%
Revenue beat(16)0
Avg Revenue beat(16)-18.72%
PT rev (1m)0%
PT rev (3m)2.69%
EPS NQ rev (1m)-0.57%
EPS NQ rev (3m)-1%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.67%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-6.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.1%
Valuation
Industry RankSector Rank
PE 36.26
Fwd PE 27
P/S 13.88
P/FCF 35.67
P/OCF 31.74
P/B 6.92
P/tB 9.81
EV/EBITDA 29.44
EPS(TTM)1.86
EY2.76%
EPS(NY)2.5
Fwd EY3.7%
FCF(TTM)1.89
FCFY2.8%
OCF(TTM)2.13
OCFY3.15%
SpS4.86
BVpS9.75
TBVpS6.88
PEG (NY)1.06
PEG (5Y)2.56
Profitability
Industry RankSector Rank
ROA 14.08%
ROE 16.96%
ROCE 14.02%
ROIC 11.08%
ROICexc 17.51%
ROICexgc 29.74%
OM 31.88%
PM (TTM) 34.03%
GM 80.16%
FCFM 38.93%
ROA(3y)8.87%
ROA(5y)3.39%
ROE(3y)10.82%
ROE(5y)3.84%
ROIC(3y)4.95%
ROIC(5y)N/A
ROICexc(3y)8.02%
ROICexc(5y)N/A
ROICexgc(3y)18.88%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y0.21%
F-Score8
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 58.42%
Cap/Sales 4.82%
Interest Coverage 250
Cash Conversion 109%
Profit Quality 114.41%
Current Ratio 8.26
Quick Ratio 7.6
Altman-Z 20.51
F-Score8
WACC14.02%
ROIC/WACC0.79
Cap/Depr(3y)40.89%
Cap/Depr(5y)40.05%
Cap/Sales(3y)4.58%
Cap/Sales(5y)5.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.49%
EPS 3Y10.73%
EPS 5Y14.14%
EPS Q2Q%19.15%
EPS Next Y34.33%
EPS Next 2Y25.14%
EPS Next 3Y20.68%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%18.46%
Revenue Next Year21.91%
Revenue Next 2Y17.32%
Revenue Next 3Y16.47%
Revenue Next 5Y9.86%
EBIT growth 1Y161.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.85%
EBIT Next 3Y17.46%
EBIT Next 5Y15.13%
FCF growth 1Y-12.1%
FCF growth 3Y3.46%
FCF growth 5Y17.82%
OCF growth 1Y-9.87%
OCF growth 3Y1.82%
OCF growth 5Y17.59%